Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. OGN
OGN logo

OGN

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

OGN News

Investor Rights Law Firm Investigates Multiple Companies

Jun 25 2026PRnewswire

Jefferies Reports Doubling of Profit in Q2 Amid Strong Investment Banking Trends

Jun 24 2026Newsfilter

Organon and Henlius Launch Biosimilars in Canada

Jun 23 2026seekingalpha

Organon Launches New Biosimilars in Canada

Jun 23 2026Newsfilter

Investigation Alerts for Multiple Company Mergers

Jun 22 2026Globenewswire

Organon Completes Global Licensing Agreement for MIUDELLA

Jun 22 2026Newsfilter

Arletta Pharma Appoints New Chief Medical Officer

Jun 19 2026Yahoo Finance

Investors' Rights Investigation and Potential Violations

Jun 17 2026Globenewswire

Organon Receives FDA Approval for TOFIDENCE New Indications

Jun 10 2026Newsfilter

Investor Rights Law Firm Investigates Multiple Companies for Potential Violations

Jun 10 2026Globenewswire

Investor Alert: Investigations into Multiple Mergers

Jun 09 2026Globenewswire

Pharmaceutical Giants Accelerate Acquisitions to Offset Patent Cliffs

Jun 05 2026stocktwits

Organon to Present New Research Findings at ISPOR 2026

May 15 2026Newsfilter

Investor Rights Law Firm Investigates Multiple Companies

May 14 2026PRnewswire

Investigations into Multiple Company Acquisitions

May 14 2026Globenewswire

Investor Rights Law Firm Investigates Multiple Companies

May 07 2026Globenewswire